Stay updated on BA3071 in PD-1 Combo for Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.

Latest updates to the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion criteria for the BA3071 study, while retaining the name of the drug and its revision number.SummaryDifference13%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to BA3071 in PD-1 Combo for Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BA3071 in PD-1 Combo for Solid Tumors Clinical Trial page.